• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Evaluating One-Year Mortality as a Quality Endpoint After Liver Resection.

作者信息

Saadat Lily V, D'Angelica Michael

机构信息

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.

出版信息

Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18272-y.

DOI:10.1245/s10434-025-18272-y
PMID:40866635
Abstract
摘要

相似文献

1
ASO Author Reflections: Evaluating One-Year Mortality as a Quality Endpoint After Liver Resection.ASO作者反思：评估肝切除术后一年死亡率作为质量终点指标。
Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18272-y.
2
ASO Author Reflections: Tumor Size as a Determinant of Anatomic Resection Benefit in Intrahepatic Cholangiocarcinoma.ASO作者反思：肿瘤大小作为肝内胆管癌解剖性切除获益的决定因素
Ann Surg Oncol. 2025 Apr 13. doi: 10.1245/s10434-025-17315-8.
3
ASO Author Reflections: Textbook Outcomes Following Liver Resection for Hepatic Neoplasms: A Realizable and Predictable Surgical Endpoint in the Real-World Scenario.ASO作者反思：肝肿瘤肝切除术后的教科书式结局：现实场景中可实现且可预测的手术终点
Ann Surg Oncol. 2024 Nov;31(12):7904-7905. doi: 10.1245/s10434-024-16102-1. Epub 2024 Aug 21.
4
ASO Author Reflections: Evaluating the Impact of Wider Adoption of Minimally Invasive Liver Resection.美国外科医师学会作者反思：评估更广泛采用微创肝切除术的影响
Ann Surg Oncol. 2018 Dec;25(Suppl 3):796-797. doi: 10.1245/s10434-018-6988-2. Epub 2018 Nov 1.
5
ASO Author Reflections: Composite Endpoint of Liver Surgery: Redefining Metrics for Clinical Trials.《美国外科医师学会》作者反思：肝脏手术的复合终点——重新定义临床试验指标
Ann Surg Oncol. 2025 May;32(5):3549-3550. doi: 10.1245/s10434-025-17049-7. Epub 2025 Feb 17.
6
ASO Author Reflections: Towards Personalized Cancer Therapy: The Role of ctDNA as a Biomarker in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.ASO作者反思：迈向个性化癌症治疗：循环肿瘤DNA作为生物标志物在接受肝动脉灌注治疗的不可切除结直肠癌肝转移患者中的作用
Ann Surg Oncol. 2025 Jul 21. doi: 10.1245/s10434-025-17886-6.
7
ASO Author Reflections: Shifting the Focus of pT1-2pN1 Breast Cancer: Are We Evaluating the Right Endpoint in Tailoring Adjuvant Radiation Therapy Recommendations?ASO作者反思：转移pT1-2pN1乳腺癌的关注重点：我们在制定辅助放疗建议时评估的终点是否正确？
Ann Surg Oncol. 2018 Dec;25(Suppl 3):681-682. doi: 10.1245/s10434-018-6986-4. Epub 2018 Oct 30.
8
ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver Transplantation.ASO作者反思：肝切除作为原位肝移植后肝细胞癌的主要治疗方式
Ann Surg Oncol. 2024 Dec;31(13):9223-9224. doi: 10.1245/s10434-024-16237-1. Epub 2024 Sep 14.
9
ASO Author Reflections: Feasibility of Robotic Liver and Diaphragm Resection Using Robotic Platform-Evolution of Surgical Approach for Multiorgan Abdominal Cancer Resection.ASO作者反思：使用机器人平台进行肝脏和膈肌切除的可行性——多器官腹部癌症切除手术方法的演变
Ann Surg Oncol. 2025 Apr;32(4):2489-2490. doi: 10.1245/s10434-024-16813-5. Epub 2024 Dec 31.
10
ASO Author Reflections: Exosomal miR-519a/522-5p: A Glycolytic Switch Driving PDAC Invasion and Its Potential as a Diagnostic Beacon.ASO作者反思：外泌体miR-519a/522-5p：驱动胰腺癌侵袭的糖酵解开关及其作为诊断标志物的潜力
Ann Surg Oncol. 2025 Jun 19. doi: 10.1245/s10434-025-17668-0.

本文引用的文献

1
Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy.肝实质保留手术：降低4152例恶性肿瘤切除术的发病率和死亡率
J Am Coll Surg. 2015 Apr;220(4):471-9. doi: 10.1016/j.jamcollsurg.2014.12.026. Epub 2014 Dec 27.
2
Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality.术后90天死亡率是衡量肝胆胰外科手术质量的合理指标。
Ann Surg. 2015 Dec;262(6):1071-8. doi: 10.1097/SLA.0000000000001048.